ALXN-1920

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameALXN-1920
Drug Alias NameALXN-1920
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionComplement factor H inhibitors
TargetsComplement factor H
Therapy Area/IndicationsNephrosisGlomerulonephritis, Membranous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanNew Zealand +[12
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAlexion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNephrosisGlomerulonephritis, Membranous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A